SpringerLink
Log in

Kombiniertes XEN-Baerveldt-Implantat – Prinzip und Management von Komplikationen

Combined XEN and Baerveldt implant—principles and management of complications

  • Kasuistiken
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

Zusammenfassung

Die Behandlung kongenitaler Glaukome erfordert immer besondere Expertise und oftmals den Einsatz neuartiger Methoden. Mit dem XEN-Baerveldt-Implantat steht eine Hornhautepithel schonende Alternative zu herkömmlichen Schlauchimplantaten zur Verfügung. Sollte im Verlauf keine ausreichende Drucksenkung erzielt werden können, ist durch einen Sekundäreingriff eine direkte Implantation des Baerveldt-Schlauches möglich.

Abstract

The treatment of congenital glaucoma requires special expertise and often novel surgical approaches. The combined use of a XEN and a Baerveldt implant is an alternative to conventional tube implants and may be less harmful for long-term corneal endothelial damage. If this technique does not provide sufficient long-term control of intraorbital pressure (IOP), a direct implantation of the Baerveldt tube can be easily performed in a second intervention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Yang LL, Lambert SR, Lynn MJ, Stulting RD (2004) Surgical management of glaucoma in infants and children with Peters’ anomaly: long-term structural and functional outcome. Ophthalmology 111(1):112–117 (Jan)

    Article  Google Scholar 

  2. Reichl S, Böhringer D, Richter O, Lagrèze W, Reinhard T (2018) Langzeitprognose der Peters-Anomalie. Ophthalmologe 115(4):309–313

    Article  CAS  Google Scholar 

  3. Yoshikawa H, Sotozono C, Ikeda Y, Mori K, Ueno M, Kinoshita S (2017) Long-term clinical course in eyes with Peters anomaly. Cornea 36(4):448–451

    Article  Google Scholar 

  4. Kim CS, Yim JH, Lee EK, Lee NH (2008) Changes in corneal endothelial cell density and morphology after Ahmed glaucoma valve implantation during the first year of follow up. Clin Exp Ophthalmol 36(2):142–147

    Article  Google Scholar 

  5. D’Alessandro E, Guidotti JM, Mansouri K, Mermoud A (2017) XEN-augmented Baerveldt: a new surgical technique for refractory glaucoma. J Glaucoma 26(2):e90–e92

    PubMed  Google Scholar 

  6. Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC, Tube Versus Trabeculectomy Study Group (2012) Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol 153(5):804–814.e1

    Article  Google Scholar 

  7. Grehn F, Hoffmann E, Klink T (2017) XEN-Baerveldt implantation may be helpful to avoid late corneal complications. J Glaucoma 26(11):e258–e259

    Article  Google Scholar 

  8. Stein JD, Ruiz D Jr, Belsky D, Lee PP, Sloan FA (2008) Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005. Ophthalmology 115(7):1109–1116.e7

    Article  Google Scholar 

  9. Tan AN, Webers CA, Berendschot TT, de Brabander J, de Witte PM, Nuijts RM, Schouten JS, Beckers HJ (2017) Corneal endothelial cell loss after Baerveldt glaucoma drainage device implantation in the anterior chamber. Acta Ophthalmol 95(1):91–96

    Article  Google Scholar 

  10. Nischal KK (2015) Genetics of congenital corneal opacification—impact on diagnosis and treatment. Cornea 34(Suppl 10):S24–S34

    Article  Google Scholar 

  11. Kenyon KR (1975) Mesenchymal Dysgenesis in Peter’s anomaly, sclerocornea and congenital sndothelial dystrophy. Exp Eye Res 21(2):125–142

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Augenklinik und Poliklinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55116, Mainz, Deutschland

    E. Gerstenberger, E. M. Hoffmann, V. Prokosch-Willing & F. Grehn

Authors
  1. E. Gerstenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. M. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Prokosch-Willing
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Grehn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Gerstenberger.

Ethics declarations

Interessenkonflikt

E. Gerstenberger, E.M. Hoffmann, V. Prokosch-Willing und F. Grehn geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gerstenberger, E., Hoffmann, E.M., Prokosch-Willing, V. et al. Kombiniertes XEN-Baerveldt-Implantat – Prinzip und Management von Komplikationen. Ophthalmologe 116, 879–881 (2019). https://doi.org/10.1007/s00347-018-0813-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-018-0813-y

Schlüsselwörter

Keywords

Search

Navigation